{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-036182","form_type":"8-K","ticker":"AMIX","cik":"0001617867","company_name":"Autonomix Medical, Inc.","filed_at":"2024-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.999840+00:00","generated_at":"2026-05-29T18:53:31.673995+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Autonomix Medical raises $10.0M in underwritten public offering of common and pre-funded units","bullets":["Gross proceeds of ~$10.0M from 615,500 common units (incl. 156,809 over-allotment) and 917,596 pre-funded units.","Price per common unit $6.54; per pre-funded unit $6.539; each includes a Series A warrant exercisable at $6.54 for 5 years.","Underwriters partially exercised over-allotment for 156,809 shares and Series A warrants.","Net proceeds to fund clinical trial, R&D, IP development, and working capital.","Ladenburg Thalmann sole bookrunner; offering closed Nov 25, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-036182","json":"https://secwatch.observer/filing/0001437749-24-036182.json","markdown":"https://secwatch.observer/filing/0001437749-24-036182.md","text":"https://secwatch.observer/filing/0001437749-24-036182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617867/000143774924036182/0001437749-24-036182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617867/000143774924036182/amix20241125_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T18:53:31.673995+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}